4.5 Article

Oleacein. Translation from Mediterranean Diet to Potential Antiatherosclerotic Drug

Journal

CURRENT PHARMACEUTICAL DESIGN
Volume 21, Issue 9, Pages 1205-1212

Publisher

BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1381612820666141007141137

Keywords

3,4-DHPEA-EDA; oleacein; Mediterranean diet; atherosclerosis

Ask authors/readers for more resources

Epidemiological studies suggest that the cardioprotective properties of olive oil, particularly extra-virgin type, result from a positive influence of its components, such as phenolic compounds, on the cardiovascular system. One of the most abundant phenolic compounds of extra virgin olive oil is the dialdehydic form of elenolic acid conjugated with 3, 4-(dihydroxyphenyl) ethanol (3, 4DHPEA- EDA), also known as oleacein. Due to its abundance in olive oil, it may play a special role in decreasing the progression of atherosclerosis. Some bioactivities of oleacein, such as antioxidant, anti-inflammatory, anti-proliferative and antimicrobial, were documented. There is also evidence of the bioavailability of oleacein in humans as well. However, due to the lack of clinical data, further studies are needed to provide information about the usefulness of this compound in antiatherosclerotic therapy.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available